Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
My American Story
Roads, Travel and Traffic
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Jobs
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
My American Story
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Jobs
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Biogen Idec
(NQ:
BIIB
)
213.38
-3.25 (-1.50%)
Streaming Delayed Price
Updated: 10:27 AM EDT, Jun 30, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
123,459
Open
218.00
Bid (Size)
213.01 (100)
Ask (Size)
213.76 (200)
Prev. Close
216.63
Today's Range
213.12 - 218.00
52wk Range
121.05 - 219.72
Shares Outstanding
146,800,000
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Block & Leviton LLP Announces Proposed Class Action Settlement on Behalf of Purchasers of Common Stock of Biogen, Inc. – BIIB
June 29, 2026
From
Block & Leviton LLP
Via
GlobeNewswire
Biogen to Highlight Breadth of Alzheimer’s Disease Portfolio at AAIC 2026, Including Phase 2 CELIA Data for Diranersen
June 29, 2026
From
Biogen Inc.
Via
GlobeNewswire
Performance
YTD
+20.0%
+20.0%
1 Month
+11.0%
+11.0%
3 Month
+13.8%
+13.8%
6 Month
+20.7%
+20.7%
1 Year
+69.9%
+69.9%
More News
Read More
Why Biogen (BIIB) Stock Is Up Today
June 26, 2026
Via
StockStory
Topics
Artificial Intelligence
Earnings
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biogen Inc. - BIIB
June 23, 2026
From
Pomerantz LLP
Via
GlobeNewswire
Therapeutics Stocks Q1 Recap: Benchmarking Biogen (NASDAQ:BIIB)
June 22, 2026
Via
StockStory
Topics
Artificial Intelligence
MissionIRNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Advances Novel Multiple Sclerosis Therapy Toward Phase 2 Trials
June 22, 2026
Via
Investor Brand Network
Novel Patented Myelin Drug-Discovery Strategy Targets Massive Unmet Need in Multiple Sclerosis
June 22, 2026
Via
Investor Brand Network
Biogen Expands Immunology Pipeline with Agreement to Acquire RayThera Inc.
June 17, 2026
From
Biogen Inc.
Via
GlobeNewswire
Novel Patented Myelin Drug-Discovery Strategy Targets Massive Unmet Need in Multiple Sclerosis
June 22, 2026
From
BioMedWire
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biogen Inc. - BIIB
June 16, 2026
From
Pomerantz LLP
Via
GlobeNewswire
3 Overrated Stocks Walking a Fine Line
June 15, 2026
Via
StockStory
BIIB Investors Have Opportunity to Join Biogen Inc. Fraud Investigation with the Schall Law Firm
June 10, 2026
From
Schall Law
Via
GlobeNewswire
1 Cash-Producing Stock with Impressive Fundamentals and 2 We Find Risky
June 10, 2026
Via
StockStory
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biogen Inc. - BIIB
June 09, 2026
From
Pomerantz LLP
Via
GlobeNewswire
Revolution Medicines Is Up 97% This Year: Here Are the Bull and Bear Cases for This Soaring Biotech Stock.
↗
June 05, 2026
Via
The Motley Fool
BIIB Investors Have Opportunity to Join Biogen Inc. Fraud Investigation with the Schall Law Firm
June 04, 2026
From
The Schall Law Firm
Via
Business Wire
Biogen’s Salanersen Receives FDA Breakthrough Therapy Designation for Spinal Muscular Atrophy
June 04, 2026
From
Biogen Inc.
Via
GlobeNewswire
EULAR 2026: Dapirolizumab Pegol Shows Potential to Reduce Flare Rates and Maintain Disease Control in Systemic Lupus Erythematosus
June 04, 2026
From
Biogen Inc.
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biogen Inc. - BIIB
June 02, 2026
From
Pomerantz LLP
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biogen Inc. - BIIB
May 26, 2026
From
Pomerantz LLP
Via
GlobeNewswire
MarketBeat Week in Review – 05/18 - 05/22
↗
May 23, 2026
Via
MarketBeat
Topics
Artificial Intelligence
Economy
Biogen Stock Slides After Trial Miss, But Analysts Stay Bullish
↗
May 22, 2026
Via
MarketBeat
Biogen and Denali Therapeutics Provide Update on Phase 2b LUMA Study of BIIB122 (DNL151) in Early-Stage Parkinson’s Disease
May 21, 2026
From
Denali Therapeutics Inc.
Via
GlobeNewswire
BIIB Investor Alert: Levi & Korsinsky Investigates Biogen Inc. (BIIB) for Potential Securities Fraud
May 19, 2026
From
Levi & Korsinsky, LLP
Via
Business Wire
Biogen Conference: Lupus, Kidney Programs Take Center Stage in Immunology Push
↗
May 14, 2026
Via
MarketBeat
Frequently Asked Questions
Is Biogen Idec publicly traded?
Yes, Biogen Idec is publicly traded.
What exchange does Biogen Idec trade on?
Biogen Idec trades on the Nasdaq Stock Market
What is the ticker symbol for Biogen Idec?
The ticker symbol for Biogen Idec is BIIB on the Nasdaq Stock Market
What is the current price of Biogen Idec?
The current price of Biogen Idec is 213.38
When was Biogen Idec last traded?
The last trade of Biogen Idec was at 06/30/26 10:27 AM ET
What is the market capitalization of Biogen Idec?
The market capitalization of Biogen Idec is 31.32B
How many shares of Biogen Idec are outstanding?
Biogen Idec has 31B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today